New latent tuberculosis test promises to be cheap and fast

May 22, 2012
This microfluidic chip invented at UC Davis uses DNA, coated on the gold spots, to test for gamma interferon -- a test for latent TB infection. The test promises to be cheaper and faster than existing tests. Credit: Ying Liu, UC Davis

Biomedical engineers at UC Davis have developed a microfluidic chip to test for latent tuberculosis. They hope the test will be cheaper, faster and more reliable than current testing for the disease.

"Our assay is cheaper, reusable, and gives results in real time," said Ying Liu, a research specialist working with Professor Alexander Revzin in the UC Davis Department of Biomedical Engineering.

The team has already conducted testing of blood samples from patients in China and the United States.

About one-third of the world's population is infected with the bacteria that cause tuberculosis, a disease that kills an estimated 1.5 million people worldwide every year, according to the U.S. .

Most infected people have , in which the bacteria are kept in check by the immune system. Patients become sick only when the immune system is compromised, enabling the bacteria to become active. People with HIV are at especially high risk.

Current tests for latent TB are based on detecting interferon-gamma, a disease-fighting chemical made by cells of the immune system. Commercially available tests require sending samples to a lab, and can be used just once.

Liu and Revzin used a novel approach: They coated a gold wafer with short pieces of a single-stranded known to stick specifically to interferon-gamma. They then mounted the wafer in a chip that has tiny channels for blood samples. If interferon-gamma is present in a blood sample, it sticks to the DNA, triggering an electrical signal that can be read by a clinician.

"If you see that the interferon-gamma level is high, you can diagnose latent TB," Liu said.

The researchers plan to refine the system so that the microfluidic sensor and electronic readout are integrated on a single chip.

A has been filed for the technology, and the researchers hope the test can be commercialized after . The work was supported by the National Science Foundation.

Explore further: Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks

add to favorites email to friend print save as pdf

Related Stories

Scientists find candidate for new TB vaccine

Mar 18, 2011

Scientists have discovered a protein secreted by tuberculosis (TB) bacteria that could be a promising new vaccine candidate, they report today in Proceedings of the National Academy of Sciences. The protein could also be use ...

Smoking increases risk of TB infection, study finds

Feb 27, 2007

People who smoke have a greater risk of becoming infected with tuberculosis (TB) and of having that infection turn into active TB disease, according to an analysis by researchers at the University of California, Berkeley.

New TB test reveals patients at risk, says study

Oct 20, 2008

A recently introduced blood test can reveal which patients may develop active tuberculosis (TB) much more precisely than the 100-year old TB skin test, according to a new study published today in the journal Annals of In ...

Recommended for you

Protein glue shows potential for use with biomaterials

1 hour ago

Researchers at the University of Milan in Italy have shown that a synthetic protein called AGMA1 has the potential to promote the adhesion of brain cells in a laboratory setting. This could prove helpful ...

New tool identifies therapeutic proteins in a 'snap'

Aug 21, 2014

(Phys.org) —In human and bacterial cells, glycosylation – the chemical process of attaching complex sugar molecules to proteins – is as fundamental as it gets, affecting every biological mechanism from cell signaling ...

User comments : 0